Key result
Temperature-controlled bipolar radiofrequency ablation achieved higher 12-month freedom from atrial fibrillation than resistance-controlled devices in persistent AF.
Why the study?
Different radiofrequency ablation devices deliver the same energy type but rely on individual control mechanisms to estimate efficacy, leaving their relative outcomes unclear.
Does temperature-controlled bipolar radiofrequency ablation improve freedom from atrial fibrillation compared to resistance-controlled ablation in patients with atrial fibrillation?
Observational (n=92)
Does temperature-controlled bipolar radiofrequency ablation improve freedom from atrial fibrillation compared to resistance-controlled ablation in patients with atrial fibrillation?
Temperature-controlled bipolar radiofrequency ablation is significantly more effective than resistance-controlled ablation for achieving freedom from atrial fibrillation in patients with persistent AF.
Answers are grounded in this paper and cite their sources.
May support temperature-controlled ablation in persistent AF; hypothesis-generating and should not yet change practice.
Background Different ablation devices deliver the same type of energy but use individual control mechanisms to estimate efficacy. We compared patient outcome after the application of radiofrequency ablation systems, using temperature- or resistance-control in paroxysmal and persistent atrial fibrillation (AF). Methods This is an unselected all-comers study. Patients underwent standardized left atrial (paroxysmal atrial fibrillation, [PAF] n = 31) or biatrial ablation (persistent atrial fibrillation [persAF] n = 61) with bipolar RF from October 2010 to June 2013. Patients with left atrial dilatation (up to 57 mm), reduced left ventricular (LV) function, and elderly were included. We used resistance-controlled (RC) or temperature-controlled (TC) devices. We amputated atrial appendices and checked intraoperatively for completeness of pulmonary vein exit block. All patients received implantable loop recorders. Follow-up interval was every 6 months. Antiarrhythmic medical treatment endured up to month 6. Results We reached 100% freedom from atrial fibrillation (FAF) in PAF. In perAF 19% of the RC but 82% of the TC patients reached FAF (12 months; p < 0.05). TC patients exhibited higher creatine kinase-muscle/brain (CK-MB) peak values. In persAF, CK-MB-levels correlated to FAF. No and no mortality (30 days) was evident. Twelve-month mortality did not correlate to AF type, AF duration, LV dimension, or function and age. Prolonged need of oral anticoagulants was 90.1% (RC) and 4.5% (TC). Conclusion In patients with persAF undergoing RF ablation, TC reached higher FAF than RC. Medical devices are not “the same” regarding effectiveness even if used according to manufacturer's instructions. Thus, putative application of “the same” energy is not always “the same” efficacy.
No takes yet. Share an insight, caveat, or question.
Niemann et al. (2019) conducted an observational in Paroxysmal and persistent atrial fibrillation (n=92). Temperature-controlled bipolar radiofrequency ablation vs. Resistance-controlled bipolar radiofrequency ablation was evaluated on Freedom from atrial fibrillation at 12 months in persistent AF (p=<0.05). Temperature-controlled bipolar radiofrequency ablation achieved higher 12-month freedom from atrial fibrillation than resistance-controlled devices in persistent AF.
Synapse has enriched 10 related papers. Consider them for comparative context: